[144] Vita Coco Company, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Vita Coco Company, Inc. (COCO) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,999,000, with an approximate sale date of 09/17/2025. The shares were acquired as founders shares on 09/10/2010. The filing also reports two recent 10b5-1 sales by the MICHAEL KIRBAN 2010 TRUST: 20,000 shares sold on 09/11/2025 for $780,898 and 30,000 shares sold on 09/09/2025 for $1,174,821. There are 56,822,981 shares outstanding reported on the form. The filer affirms compliance representations required under Rule 144 and 10b5-1 trading-plan attestations.
Positive
- Transparent disclosure of proposed sale under Rule 144 with broker details
- Shares acquired in 2010 as founders shares, indicating long-held position
- Recent 10b5-1 sales are reported, suggesting preplanned, compliant selling activity
Negative
- Proposed sale of 50,000 shares could be viewed negatively by some investors despite being a small percentage of outstanding shares
- Filing omits an explicit named ‘Person for Whose Account’ for the proposed sale, creating minor ambiguity about beneficial ownership of this notice
Insights
TL;DR: Routine insider sale disclosure; amount is modest relative to outstanding shares and appears executed under trading plan.
The filing documents a proposed Rule 144 sale of 50,000 founder shares acquired in 2010, routed through Morgan Stanley Smith Barney, with recent 10b5-1 executions totaling 50,000 shares across two trades earlier in September 2025. These details indicate structured, preplanned dispositions rather than ad-hoc selling. Materiality is limited: the proposed block equals roughly 0.088% of reported outstanding shares, so market impact is likely minimal. The disclosure satisfies regulatory requirements for transparency.
TL;DR: Disclosure aligns with governance and insider-trading controls; reaffirmation of no undisclosed material information included.
The notifier certifies that no material non-public information is known and references a 10b5-1 plan adoption for prior sales. That representation and the dated acquisition information support compliance with insider-trading policies. From a governance standpoint, timely filing and clear broker identification (Morgan Stanley Smith Barney) are positive controls. The filing does not disclose the beneficial owner line for the proposed sale explicitly, though past sales list the MICHAEL KIRBAN 2010 TRUST.